This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, H. Articles by Bieberich, C. J. Search for Related Content PubMed PubMed Citation Articles by Chen, H. Articles by Bieberich, C. J.

NKX-3.1 Interacts with Prostate-derived Ets Factor and Regulates the Activity of the PSA Promoter¹

Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, Maryland 21250

The NKX-3.1 homeobox gene maps to human chromosome 8p21, a region that undergoes frequent loss of heterozygosity in prostate tumors. Loss of Nkx-3.1 function in mice leads to epithelial overgrowth. To further elucidate the molecular basis of NKX-3.1 function, a genetic screen for proteins that interact with NKX-3.1 was performed. Prostate-derived Ets factor (PDEF) was identified as a potential partner of NKX-3.1. Coimmunoprecipitation analyses demonstrated that NKX-3.1 and PDEF are physically associated in prostate epithelial cells. Cotransfection analyses demonstrated that NKX-3.1 can abolish the transcriptional activation function of PDEF on the prostate-specific antigen (PSA) promoter. These data identify PSA as a target gene for NKX-3.1 and provide new insights into the function of this candidate tumor suppressor.

This article has been cited by other articles:

				Y. Zhang, R. A. Fillmore, and W. E. Zimmer Structural and Functional Analysis of Domains Mediating Interaction Between the Bagpipe Homologue, Nkx3.1 and Serum Response Factor Experimental Biology and Medicine, March 1, 2008; 233(3): 297 - 309. [Abstract] [Full Text] [PDF]

				B. Guan, P. Pungaliya, X. Li, C. Uquillas, L. N. Mutton, E. H. Rubin, and C. J. Bieberich Ubiquitination by TOPORS Regulates the Prostate Tumor Suppressor NKX3.1 J. Biol. Chem., February 22, 2008; 283(8): 4834 - 4840. [Abstract] [Full Text] [PDF]

				X. Gu, L. F. Zerbini, H. H. Otu, M. Bhasin, Q. Yang, M. G. Joseph, F. Grall, T. Onatunde, R. G. Correa, and T. A. Libermann Reduced PDEF Expression Increases Invasion and Expression of Mesenchymal Genes in Prostate Cancer Cells Cancer Res., May 1, 2007; 67(9): 4219 - 4226. [Abstract] [Full Text] [PDF]

				C. Bowen, A. Stuart, J.-H. Ju, J. Tuan, J. Blonder, T. P. Conrads, T. D. Veenstra, and E. P. Gelmann NKX3.1 Homeodomain Protein Binds to Topoisomerase I and Enhances Its Activity Cancer Res., January 15, 2007; 67(2): 455 - 464. [Abstract] [Full Text] [PDF]

				S. Chattopadhyay, E.-Y. Gong, M. Hwang, E. Park, H. J. Lee, C. Y. Hong, H.-S. Choi, J.-H. Cheong, H. B. Kwon, and K. Lee The CCAAT Enhancer-Binding Protein-{alpha} Negatively Regulates the Transactivation of Androgen Receptor in Prostate Cancer Cells Mol. Endocrinol., May 1, 2006; 20(5): 984 - 995. [Abstract] [Full Text] [PDF]

				X. Li, B. Guan, S. Maghami, and C. J. Bieberich NKX3.1 Is Regulated by Protein Kinase CK2 in Prostate Tumor Cells Mol. Cell. Biol., April 15, 2006; 26(8): 3008 - 3017. [Abstract] [Full Text] [PDF]

				P. Thelen, J.-G. Scharf, P. Burfeind, B. Hemmerlein, W. Wuttke, B. Spengler, V. Christoffel, R.-H. Ringert, and D. Seidlova-Wuttke Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer Carcinogenesis, August 1, 2005; 26(8): 1360 - 1367. [Abstract] [Full Text] [PDF]

				C Hughes, A Murphy, C Martin, O Sheils, and J O'Leary Molecular pathology of prostate cancer J. Clin. Pathol., July 1, 2005; 58(7): 673 - 684. [Abstract] [Full Text] [PDF]

				G. S. Palapattu, S. Sutcliffe, P. J. Bastian, E. A. Platz, A. M. De Marzo, W. B. Isaacs, and W. G. Nelson Prostate carcinogenesis and inflammation: emerging insights Carcinogenesis, July 1, 2005; 26(7): 1170 - 1181. [Abstract] [Full Text] [PDF]

				I. J. Edwards, I. M. Berquin, H. Sun, J. T. O'Flaherty, L. W. Daniel, M. J. Thomas, L. L. Rudel, R. L. Wykle, and Y. Q. Chen Differential Effects of Delivery of Omega-3 Fatty Acids to Human Cancer Cells by Low-Density Lipoproteins versus Albumin Clin. Cancer Res., December 15, 2004; 10(24): 8275 - 8283. [Abstract] [Full Text] [PDF]

				J. L. Kirby, L. Yang, J. C. Labus, R. J. Lye, N. Hsia, R. Day, G. A. Cornwall, and B. T. Hinton Characterization of Epididymal Epithelial Cell-Specific Gene Promoters by In Vivo Electroporation Biol Reprod, August 1, 2004; 71(2): 613 - 619. [Abstract] [Full Text] [PDF]

				B.-C. Jeong, C. Y. Hong, S. Chattopadhyay, J. H. Park, E.-Y. Gong, H.-J. Kim, S.-Y. Chun, and K. Lee Androgen Receptor Corepressor-19 kDa (ARR19), a Leucine-Rich Protein that Represses the Transcriptional Activity of Androgen Receptor through Recruitment of Histone Deacetylase Mol. Endocrinol., January 1, 2004; 18(1): 13 - 25. [Abstract] [Full Text] [PDF]

				W. G. Nelson, A. M. De Marzo, and W. B. Isaacs Prostate Cancer N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381. [Full Text] [PDF]

				S. I. Mohammed, B. A. Craig, A. J. Mutsaers, N. W. Glickman, P. W. Snyder, A. E. deGortari, D. L. Schlittler, K. T. Coffman, P. L. Bonney, and D. W. Knapp Effects of the Cyclooxygenase Inhibitor, Piroxicam, in Combination with Chemotherapy on Tumor Response, Apoptosis, and Angiogenesis in a Canine Model of Human Invasive Urinary Bladder Cancer Mol. Cancer Ther., February 1, 2003; 2(2): 183 - 188. [Abstract] [Full Text] [PDF]